Americas COVID-19 Testing Market valuation is at US$ 5.1 Billion in 2022 and likely to be valued at US$ 9.8 Billion by 2033. The sales of America’s COVID-19 testing are growing at a CAGR of 6.7% during the forecast period.The expanding number of COVID-19-infected individuals, treatment procedures, and R&D activities.